AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34371963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 33138363 — intervention group
Group type: EXPERIMENTAL
Intervention: MP2-based machine learning representation
Number of subjects: 140
Study 34536265 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor antagonists (MRAs)
Number of subjects: 4397
Study 34536265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4397
Study 34859634 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser combined with ethylenediamine tetra acetic acid (EDTA)
Number of subjects: 30
Study 34859634 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 30
Study 32114996 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II added to standard of care (SOC)
Number of subjects: 0
Study 32114996 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 0
Study 32202619 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimicronutrient group A (7 micronutrients at RDA)
Number of subjects: 190
Study 32202619 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimicronutrient group B (22 micronutrients at RDA)
Number of subjects: 190
Study 32202619 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimicronutrient group C (22 micronutrients at 3RDA)
Number of subjects: 190
Study 35753964 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored over-the-counter medication safety intervention
Number of subjects: 0
Study 35753964 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34945739 — intervention group
Group type: COMPARATOR
Intervention: Control (saline bolus and midazolam infusion [0.05 mg/kg loading, 20 µg/kg/h thereafter])
Number of subjects: 120
Study 34945739 — intervention group
Group type: EXPERIMENTAL
Intervention: DMED (saline bolus and dexmedetomidine infusion [1 µg/kg loading, 0.4 µg/kg/h thereafter])
Number of subjects: 120
Study 34945739 — intervention group
Group type: EXPERIMENTAL
Intervention: DEXA (dexamethasone [10 mg] bolus and midazolam infusion)
Number of subjects: 120
Study 34945739 — intervention group
Group type: EXPERIMENTAL
Intervention: DMED‐DEXA (dexmedetomidine infusion and dexamethasone bolus)
Number of subjects: 120
Study 32036754 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality Improvement Project (QIP) interventions including improving IT access, education event, and reminder emails for clinicians.
Number of subjects: 30
Study 32036754 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality Improvement Project (QIP) interventions
Number of subjects: 30
Study 32061297 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0
Study 32061297 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34964676 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiology-based software-guided cochlear implant fitting method (5-electrode method)
Number of subjects: 48
Study 34964676 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiology-based software-guided cochlear implant fitting method (all 22 electrodes)
Number of subjects: 48
Study 34964676 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical software fitting method
Number of subjects: 48
Study 33559436 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion
Number of subjects: 66
Study 33559436 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupuncture and sham-moxibustion
Number of subjects: 66
Study 32498266 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent dairy consumption (FR)
Number of subjects: 45
Study 32498266 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy consumption (general)
Number of subjects: 45
Study 36102392 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (COPLA) with standard medical care
Number of subjects: 29
Study 36102392 — intervention group
Group type: COMPARATOR
Intervention: Fresh frozen plasma (FFP) with standard medical care
Number of subjects: 29
Study 33713361 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial removable dental prosthesis (PRDP)
Number of subjects: 152
Study 33713361 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened dental arch (SDA)
Number of subjects: 152
Study 33713361 — intervention group
Group type: COMPARATOR
Intervention: Both PRDP and SDA groups
Number of subjects: 152
Study 32162287 — intervention group
Group type: EXPERIMENTAL
Intervention: Fork-tip fine-needle biopsy (FNB)
Number of subjects: 108
Study 32162287 — intervention group
Group type: COMPARATOR
Intervention: Fine-needle aspiration (FNA)
Number of subjects: 108
Study 35798475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrathin, biodegradable-polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 1440
Study 35798475 — intervention group
Group type: COMPARATOR
Intervention: Thin, durable-polymer everolimus-eluting stent (DP-EES)
Number of subjects: 1440
Study 33387486 — intervention group
Group type: EXPERIMENTAL
Intervention: CLEAR (levofloxacin, ethambutol, azithromycin, and rifabutin)
Number of subjects: 97
Study 33387486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 33387486 — intervention group
Group type: EXPERIMENTAL
Intervention: CLEAR
Number of subjects: 97
Study 35393614 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily
Number of subjects: 15427
Study 35393614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15427
Study 32517693 — intervention group
Group type: EXPERIMENTAL
Intervention: erenumab 70 mg
Number of subjects: 70
Study 32517693 — intervention group
Group type: EXPERIMENTAL
Intervention: erenumab 140 mg
Number of subjects: 70
Study 32517693 — intervention group
Group type: EXPERIMENTAL
Intervention: erenumab 70 mg and 140 mg
Number of subjects: 70
Study 34229690 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle and body weight recommendations adherence
Number of subjects: 1000
Study 34229690 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior Change Techniques
Number of subjects: 1000
Study 34229690 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research methods (semi-structured interviews, focus groups)
Number of subjects: 1000
Study 34327583 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-QUAL score assessment by two radiologists
Number of subjects: 103
Study 34327583 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-QUAL score assessment clustered into three groups (PI-QUAL 1-2 vs PI-QUAL 3 vs PI-QUAL 4-5)
Number of subjects: 103
Study 34327583 — intervention group
Group type: EXPERIMENTAL
Intervention: T2-weighted imaging
Number of subjects: 103
Study 34327583 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic contrast-enhanced sequences
Number of subjects: 103
Study 34327583 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted imaging
Number of subjects: 103
Study 32162721 — intervention group
Group type: EXPERIMENTAL
Intervention: Tildrakizumab 100 mg Q12W
Number of subjects: 2117
Study 32162721 — intervention group
Group type: EXPERIMENTAL
Intervention: Tildrakizumab 200 mg Q12W
Number of subjects: 2117
Study 32162721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2117
Study 36078691 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacutaneous Fibrolysis (DF)
Number of subjects: 44
Study 36078691 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 44
Study 33060493 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 30
Study 33060493 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 30
Study 33060493 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 30
Study 32667383 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 60
Study 32667383 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping
Number of subjects: 60
Study 32667383 — intervention group
Group type: COMPARATOR
Intervention: No taping (control)
Number of subjects: 60
Study 35113228 — intervention group
Group type: EXPERIMENTAL
Intervention: Trocar-less trans-vaginal mesh (TTMs)
Number of subjects: 59
Study 35113228 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic pelvic organ prolapse surgery (POPs)
Number of subjects: 59
Study 33252480 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg daily (10 mg if co-administered with ritonavir/cobicistat)
Number of subjects: 88
Study 33252480 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 88
Study 33252480 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin
Number of subjects: 88
Study 32236822 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction (mitoxantrone or cyclophosphamide)
Number of subjects: 813
Study 32236822 — intervention group
Group type: COMPARATOR
Intervention: Escalation (interferon beta)
Number of subjects: 813
Study 35461831 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept or bevacizumab treatment
Number of subjects: 330
Study 33812296 — intervention group
Group type: EXPERIMENTAL
Intervention: Family participatory dignity therapy (2-3 interviews lasting 45-60 minutes each)
Number of subjects: 68
Study 33812296 — intervention group
Group type: EXPERIMENTAL
Intervention: Family participatory dignity therapy
Number of subjects: 68
Study 33812296 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 68
Study 35031969 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis CCT 7858 at 9 × 10^10 CFU concentration
Number of subjects: 104
Study 35031969 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 104
Study 35031969 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis CCT 7858
Number of subjects: 104
Study 33626296 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion of vaccinomics
Number of subjects: 0
Study 32716206 — intervention group
Group type: EXPERIMENTAL
Intervention: Suxiao Jiuxin Pill (SJP)
Number of subjects: 200
Study 32716206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 34879916 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue strength exercise
Number of subjects: 10
Study 32349716 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-avoidance NCCs located on the left side of the package
Number of subjects: 365
Study 32349716 — intervention group
Group type: EXPERIMENTAL
Intervention: Benefit-seeking NCCs located on the right side of the package
Number of subjects: 365
Study 33722583 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-101
Number of subjects: 33
Study 33722583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 33238677 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (0.5 ml/kg)
Number of subjects: 270
Study 33238677 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (0.6 ml/kg)
Number of subjects: 270
Study 33238677 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (0.8 ml/kg, flow rate 5 ml/s)
Number of subjects: 270
Study 33238677 — intervention group
Group type: COMPARATOR
Intervention: Flow rates of contrast agents
Number of subjects: 270
Study 33238677 — intervention group
Group type: COMPARATOR
Intervention: Amount of contrast agent
Number of subjects: 270
Study 33238677 — intervention group
Group type: COMPARATOR
Intervention: Effective dose (ED)
Number of subjects: 270
Study 36277012 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, labetalol, and magnesium sulfate
Number of subjects: 100
Study 36277012 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine combined with magnesium sulfate
Number of subjects: 100
Study 33189876 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping With Stress (CWS), a cognitive-behavioral program
Number of subjects: 204
Study 33189876 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST), an interpersonal program
Number of subjects: 204
Study 33189876 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched adolescents
Number of subjects: 204
Study 32147070 — intervention group
Group type: EXPERIMENTAL
Intervention: Licorice pastille
Number of subjects: 70
Study 34839364 — intervention group
Group type: EXPERIMENTAL
Intervention: KET 0.5 (0.5 mg/kg)
Number of subjects: 33
Study 34839364 — intervention group
Group type: COMPARATOR
Intervention: MID (midazolam 0.03 mg/kg)
Number of subjects: 33
Study 34930986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 248
Study 34930986 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 248
Study 34930986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin combined with Metformin
Number of subjects: 248
Study 33502265 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment for Insomnia (BBTI)
Number of subjects: 46
Study 32146042 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial AP bowing assessment
Number of subjects: 211
Study 32146042 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial lateral bowing assessment
Number of subjects: 211
Study 32146042 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulnar AP bowing assessment
Number of subjects: 211
Study 32146042 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulnar lateral bowing assessment
Number of subjects: 211
Study 32146042 — intervention group
Group type: EXPERIMENTAL
Intervention: Side-to-side differences assessment
Number of subjects: 211
Study 36097559 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin 200 mg
Number of subjects: 24
Study 36097559 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin 400 mg
Number of subjects: 24
Study 36097559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33666026 — intervention group
Group type: EXPERIMENTAL
Intervention: Lever positioning manipulation
Number of subjects: 67
Study 33666026 — intervention group
Group type: COMPARATOR
Intervention: Lumbar slanting manipulation
Number of subjects: 67
Study 32020660 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonjudgment mindfulness
Number of subjects: 120
Study 32020660 — intervention group
Group type: EXPERIMENTAL
Intervention: General mindfulness
Number of subjects: 120
Study 32020660 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation
Number of subjects: 120
Study 32020660 — intervention group
Group type: COMPARATOR
Intervention: Nothing
Number of subjects: 120
Study 34657640 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arabinose (7.5 g) co-ingested with sucrose (50 g)
Number of subjects: 12
Study 34657640 — intervention group
Group type: COMPARATOR
Intervention: Control (sucrose 50 g without L-arabinose)
Number of subjects: 12
Study 33811444 — intervention group
Group type: EXPERIMENTAL
Intervention: CPCs alone
Number of subjects: 125
Study 33811444 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCs alone
Number of subjects: 125
Study 33811444 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCs + CPCs
Number of subjects: 125
Study 33811444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 32729334 — intervention group
Group type: EXPERIMENTAL
Intervention: Platycodon grandiflorum (PG)
Number of subjects: 125
Study 32729334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 32729334 — intervention group
Group type: COMPARATOR
Intervention: Platycodon grandiflorum (PG) and Placebo
Number of subjects: 125
Study 35240074 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag 60 mg once daily for 5 days before and after chemotherapy
Number of subjects: 122
Study 35240074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 35240074 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag (per protocol)
Number of subjects: 122
Study 35240074 — intervention group
Group type: COMPARATOR
Intervention: Placebo (per protocol)
Number of subjects: 122
Study 35240074 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag
Number of subjects: 122
Study 34186380 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea mouthwash (100 ml for 60 seconds after brushing)
Number of subjects: 63
Study 34186380 — intervention group
Group type: COMPARATOR
Intervention: Tap water mouthwash (100 ml for 60 seconds after brushing)
Number of subjects: 63
Study 34186380 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea mouthwash
Number of subjects: 63
Study 34186380 — intervention group
Group type: COMPARATOR
Intervention: Tap water mouthwash
Number of subjects: 63
Study 34348743 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention comprising academic detailing, enrolment in a community of practice, and resources
Number of subjects: 86
Study 34348743 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 86
Study 34348743 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 86
Study 35987671 — intervention group
Group type: EXPERIMENTAL
Intervention: SMILe‐ICM
Number of subjects: 80
Study 35987671 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study 33523511 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-arm trials using historical controls
Number of subjects: 0
Study 33523511 — intervention group
Group type: COMPARATOR
Intervention: Standard randomized controlled clinical trials
Number of subjects: 0
Study 32313988 — intervention group
Group type: COMPARATOR
Intervention: No DVT
Number of subjects: 251
Study 32313988 — intervention group
Group type: EXPERIMENTAL
Intervention: DVT
Number of subjects: 251
Study 36222372 — intervention group
Group type: EXPERIMENTAL
Intervention: Danofloxacin 5 mg/kg body weight, administered orally (PO)
Number of subjects: 18
Study 36222372 — intervention group
Group type: EXPERIMENTAL
Intervention: Danofloxacin 5 mg/kg body weight, administered intravenously (IV)
Number of subjects: 18
Study 33753443 — intervention group
Group type: EXPERIMENTAL
Intervention: Hopewell Hospitalist video game intervention
Number of subjects: 30
Study 32791711 — intervention group
Group type: EXPERIMENTAL
Intervention: rMS at HT7 acupoint
Number of subjects: 45
Study 32791711 — intervention group
Group type: COMPARATOR
Intervention: rTMS at r-DLPFC
Number of subjects: 45
Study 32791711 — intervention group
Group type: COMPARATOR
Intervention: No treatment (waiting treatment)
Number of subjects: 45
Study 32791711 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (rMS, rTMS, No treatment)
Number of subjects: 45
Study 35419607 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (NIVO) + Radiotherapy (RT)
Number of subjects: 560
Study 35419607 — intervention group
Group type: COMPARATOR
Intervention: Temozolomide (TMZ) + Radiotherapy (RT)
Number of subjects: 560
Study 33620901 — intervention group
Group type: COMPARATOR
Intervention: Phone counseling
Number of subjects: 84
Study 33620901 — intervention group
Group type: COMPARATOR
Intervention: Office counseling
Number of subjects: 84
Study 33620901 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study 32069352 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved nutrition in early life
Number of subjects: 1112
Study 32069352 — intervention group
Group type: COMPARATOR
Intervention: Unexposed women
Number of subjects: 1112
Study 32069352 — intervention group
Group type: COMPARATOR
Intervention: Unexposed men
Number of subjects: 1112
Study 36454876 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic strength training (IST)
Number of subjects: 52
Study 36454876 — intervention group
Group type: COMPARATOR
Intervention: Thera-Band resistance training (TBT)
Number of subjects: 52
Study 34237132 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior quadratus lumborum block with multimodal analgesia (30 ml bupivacaine 0.5% with 2 mg preservative-free dexamethasone)
Number of subjects: 96
Study 34237132 — intervention group
Group type: COMPARATOR
Intervention: Multimodal analgesia alone
Number of subjects: 96
Study 34237132 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (anterior quadratus lumborum block and multimodal analgesia alone)
Number of subjects: 96
Study 34003054 — intervention group
Group type: EXPERIMENTAL
Intervention: Five clinical scoring systems (adult appendicitis, appendicitis inflammatory response, modified Alvarado, Broek, and Christian scores)
Number of subjects: 2888
Study 36216650 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose quadrivalent influenza vaccine (QIV-HD)
Number of subjects: 165
Study 36216650 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose quadrivalent influenza vaccine (QIV-SD)
Number of subjects: 165
Study 34867500 — intervention group
Group type: EXPERIMENTAL
Intervention: Laypeople-delivered community psychiatric rehabilitation
Number of subjects: 94
Study 34543873 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 7
Study 34543873 — intervention group
Group type: COMPARATOR
Intervention: False acupuncture/sham
Number of subjects: 7
Study 32919210 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSS (Post-Traumatic Stress Symptoms)
Number of subjects: 291
Study 32919210 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSS in girls
Number of subjects: 291
Study 32919210 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSS in boys
Number of subjects: 291
Study 32919210 — intervention group
Group type: COMPARATOR
Intervention: Trauma exposure
Number of subjects: 291
Study 36098037 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus nab-paclitaxel
Number of subjects: 196
Study 36098037 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 196
Study 32871454 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Bifidobacterium breve M16-V)
Number of subjects: 67
Study 32871454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 35644959 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNO-assisted early extubation (Group H)
Number of subjects: 40
Study 35644959 — intervention group
Group type: COMPARATOR
Intervention: Conventional extubation (Group C)
Number of subjects: 40
Study 33230964 — intervention group
Group type: EXPERIMENTAL
Intervention: Large Changes (produce buffer by losing 5-10 pounds initially)
Number of subjects: 599
Study 33230964 — intervention group
Group type: EXPERIMENTAL
Intervention: Small Changes (daily small changes in intake and activity)
Number of subjects: 599